<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Current Computer-Aided Drug Design</journal-id><journal-title-group><journal-title xml:lang="en">Current Computer-Aided Drug Design</journal-title><trans-title-group xml:lang="ru"><trans-title>Current Computer-Aided Drug Design</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1573-4099</issn><issn publication-format="electronic">1875-6697</issn><publisher><publisher-name xml:lang="en">Bentham Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">644540</article-id><article-id pub-id-type="doi">10.2174/0115734099259071231115072421</article-id><article-categories><subj-group subj-group-type="toc-heading"><subject>Chemistry</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Network Pharmacology and Bioinformatics Analyses Identify the Core Genes and Pyroptosis-Related Mechanisms of Nardostachys Chinensis for Atrial Fibrillation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Xue</surname><given-names>Weiqi</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Luo</surname><given-names>Yuan</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>He</surname><given-names>Weifeng</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Mengyuan</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Huanyi</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name><surname>Qing</surname><given-names>Lijin</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff id="aff1"><institution>First School of Clinical Medicine, Guangzhou University of Chinese Medicine</institution></aff><aff id="aff2"><institution>, First Affiliated Hospital of Guangzhou University of Chinese Medicine</institution></aff><pub-date date-type="pub" iso-8601-date="2024-07-01" publication-format="electronic"><day>01</day><month>07</month><year>2024</year></pub-date><volume>20</volume><issue>7</issue><issue-title xml:lang="ru"/><fpage>1070</fpage><lpage>1086</lpage><history><date date-type="received" iso-8601-date="2025-01-07"><day>07</day><month>01</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Bentham Science Publishers</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Bentham Science Publishers</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://rjeid.com/1573-4099/article/view/644540">https://rjeid.com/1573-4099/article/view/644540</self-uri><abstract xml:lang="en"><p id="idm46041443644368">Background:Nardostachys chinensis is an herbal medicine widely used in the treatment of atrial fibrillation (AF), but the mechanism is unclear.</p><p id="idm46041443648368">Objective:To explore the molecular mechanism of N. chinensis against AF.</p><p id="idm46041443652336">Methods:The TCMSP was used to screen the active N. chinensis compounds and their targets. Differentially expressed genes (DEGs) for AF were identified using open-access databases. Using Venn diagrams, the cross-targets of N. chinensis, pyroptosis, and AF were obtained. The genes underwent molecular docking as well as gene set enrichment analysis (GSEA). A nomogram based on candidate genes was constructed and evaluated with the clinical impact curve. After that, the immune infiltration of the dataset was analyzed by single sample GSEA (ssGSEA). Finally, microRNAs (miRNAs) and transcription factors (TFs) were predicted based on candidate genes.</p><p id="idm46041443657392">Results:Tumor necrosis factor (TNF) and caspase-8 (CASP8) were obtained as candidate genes by taking the intersection of DEGs, targets of N. chinensis, and pyroptosis-related genes. Tolllike receptor (TLR) and peroxisome proliferator-activated receptor (PPAR) signaling pathways were linked to candidate genes. Additionally, immune cell infiltration analysis revealed that CASP8 was associated with natural killer T cells, natural killer cells, regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSC), macrophages, CD8 T cells, and CD4 T cells. Finally, miR-34a-5p and several TFs were found to regulate the expression of CASP8 and TNF.</p><p id="idm46041443666768">Conclusion:CASP8 and TNF are potential targets of N. chinensis intervention in pyroptosisrelated AF, and the TLR/NLRP3 signaling pathway may be associated with this process.</p></abstract><kwd-group xml:lang="en"><kwd>Atrial fibrillation</kwd><kwd>Nardostachys chinensis</kwd><kwd>pyroptosis</kwd><kwd>bioinformatic analysis</kwd><kwd>network pharmacology</kwd><kwd>immune cell infiltration.</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Chugh, S.S.; Havmoeller, R.; Narayanan, K.; Singh, D.; Rienstra, M.; Benjamin, E.J.; Gillum, R.F.; Kim, Y.H.; McAnulty, J.H., Jr; Zheng, Z.J.; Forouzanfar, M.H.; Naghavi, M.; Mensah, G.A.; Ezzati, M.; Murray, C.J.L. Worldwide epidemiology of atrial fibrillation: A Global Burden of Disease 2010 Study. Circulation, 2014, 129(8), 837-847. doi: 10.1161/CIRCULATIONAHA.113.005119 PMID: 24345399</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Kirchhof, P.; Benussi, S.; Kotecha, D.; Ahlsson, A.; Atar, D.; Casadei, B.; Castella, M.; Diener, H.C.; Heidbuchel, H.; Hendriks, J.; Hindricks, G.; Manolis, A.S.; Oldgren, J.; Popescu, B.A.; Schotten, U.; Van Putte, B.; Vardas, P.; Agewall, S.; Camm, J.; Baron Esquivias, G.; Budts, W.; Carerj, S.; Casselman, F.; Coca, A.; De Caterina, R.; Deftereos, S.; Dobrev, D.; Ferro, J.M.; Filippatos, G.; Fitzsimons, D.; Gorenek, B.; Guenoun, M.; Hohnloser, S.H.; Kolh, P.; Lip, G.Y.H.; Manolis, A.; McMurray, J.; Ponikowski, P.; Rosenhek, R.; Ruschitzka, F.; Savelieva, I.; Sharma, S.; Suwalski, P.; Tamargo, J.L.; Taylor, C.J.; Van Gelder, I.C.; Voors, A.A.; Windecker, S.; Zamorano, J.L.; Zeppenfeld, K. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace, 2016, 18(11), 1609-1678. doi: 10.1093/europace/euw295 PMID: 27567465</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Camm, A.J.; Lip, G.Y.H.; De Caterina, R.; Savelieva, I.; Atar, D.; Hohnloser, S.H.; Hindricks, G.; Kirchhof, P.; Bax, J.J.; Baumgartner, H.; Ceconi, C.; Dean, V.; Deaton, C.; Fagard, R.; Funck-Brentano, C.; Hasdai, D.; Hoes, A.; Kirchhof, P.; Knuuti, J.; Kolh, P.; McDonagh, T.; Moulin, C.; Popescu, B.A.; Reiner, .; Sechtem, U.; Sirnes, P.A.; Tendera, M.; Torbicki, A.; Vahanian, A.; Windecker, S.; Vardas, P.; Al-Attar, N.; Alfieri, O.; Angelini, A.; Blömstrom-Lundqvist, C.; Colonna, P.; De Sutter, J.; Ernst, S.; Goette, A.; Gorenek, B.; Hatala, R.; Heidbüchel, H.; Heldal, M.; Kristensen, S.D.; Kolh, P.; Le Heuzey, J-Y.; Mavrakis, H.; Mont, L.; Filardi, P.P.; Ponikowski, P.; Prendergast, B.; Rutten, F.H.; Schotten, U.; Van Gelder, I.C.; Verheugt, F.W.A. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. Eur. Heart J., 2012, 33(21), 2719-2747. doi: 10.1093/eurheartj/ehs253 PMID: 22922413</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Trigo, P.; Fischer, G.W. Managing atrial fibrillation in the elderly: Critical appraisal of dronedarone. Clin. Interv. Aging, 2012, 7, 1-13. PMID: 22291468</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Henry, L.; Ad, N. The surgical treatment for atrial fibrillation: Ablation technology and surgical approaches. Rambam Maimonides ME., 2013, 4(3), 15-19.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Katz, E.S.; Tsiamtsiouris, T.; Applebaum, R.M.; Schwartzbard, A.; Tunick, P.A.; Kronzon, I. Surgical left atrial appendage ligation is frequently incomplete: A transesophageal echocardiographic study. J. Am. Coll. Cardiol., 2000, 36(2), 468-471. doi: 10.1016/S0735-1097(00)00765-8 PMID: 10933359</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Wijesurendra, R.S.; Casadei, B. Mechanisms of atrial fibrillation. Heart, 2019, 105(24), 1860-1867. doi: 10.1136/heartjnl-2018-314267 PMID: 31444267</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Andrade, J.; Khairy, P.; Dobrev, D.; Nattel, S. The clinical profile and pathophysiology of atrial fibrillation: Relationships among clinical features, epidemiology, and mechanisms. Circ. Res., 2014, 114(9), 1453-1468. doi: 10.1161/CIRCRESAHA.114.303211 PMID: 24763464</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Khoury, M.K.; Gupta, K.; Franco, S.R.; Liu, B. Necroptosis in the pathophysiology of disease. Am. J. Pathol., 2020, 190(2), 272-285. doi: 10.1016/j.ajpath.2019.10.012 PMID: 31783008</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Zychlinsky, A.; Prevost, M.C.; Sansonetti, P.J. Shigella flexneri induces apoptosis in infected macrophages. Nature, 1992, 358(6382), 167-169. doi: 10.1038/358167a0 PMID: 1614548</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>DSouza, C.A.; Heitman, J. Dismantling the cryptococcus coat. Trends Microbiol., 2001, 9(3), 112-113. doi: 10.1016/S0966-842X(00)01945-4 PMID: 11303499</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Frank, D.; Vince, J.E. Pyroptosis versus necroptosis: Similarities, differences, and crosstalk. Cell Death Differ., 2019, 26(1), 99-114. doi: 10.1038/s41418-018-0212-6 PMID: 30341423</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Martinon, F.; Burns, K.; Tschopp, J. The inflammasome. Mol. Cell, 2002, 10(2), 417-426. doi: 10.1016/S1097-2765(02)00599-3 PMID: 12191486</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Xia, S.; Hollingsworth, L.R., IV; Wu, H. Mechanism and regulation of gasdermin-mediated cell death. Cold Spring Harb. Perspect. Biol., 2020, 12(3), a036400. doi: 10.1101/cshperspect.a036400 PMID: 31451512</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Newton, K.; Wickliffe, K.E.; Maltzman, A.; Dugger, D.L.; Reja, R.; Zhang, Y.; Roose-Girma, M.; Modrusan, Z.; Sagolla, M.S.; Webster, J.D.; Dixit, V.M. Activity of caspase-8 determines plasticity between cell death pathways. Nature, 2019, 575(7784), 679-682. doi: 10.1038/s41586-019-1752-8 PMID: 31723262</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Moujalled, D.; Strasser, A.; Liddell, J.R. Molecular mechanisms of cell death in neurological diseases. Cell Death Differ., 2021, 28(7), 2029-2044. doi: 10.1038/s41418-021-00814-y PMID: 34099897</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Sharma, B.R.; Kanneganti, T.D. NLRP3 inflammasome in cancer and metabolic diseases. Nat. Immunol., 2021, 22(5), 550-559. doi: 10.1038/s41590-021-00886-5 PMID: 33707781</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Shen, H.H.; Yang, Y.X.; Meng, X.; Luo, X.Y.; Li, X.M.; Shuai, Z.W.; Ye, D.Q.; Pan, H.F. NLRP3: A promising therapeutic target for autoimmune diseases. Autoimmun. Rev., 2018, 17(7), 694-702. doi: 10.1016/j.autrev.2018.01.020 PMID: 29729449</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Zhaolin, Z.; Guohua, L.; Shiyuan, W.; Zuo, W. Role of pyroptosis in cardiovascular disease. Cell Prolif., 2019, 52(2), e12563. doi: 10.1111/cpr.12563 PMID: 30525268</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Alvarez-Erviti, L.; Couch, Y.; Richardson, J.; Cooper, J.M.; Wood, M.J.A. Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line. Neurosci. Res., 2011, 69(4), 337-342. doi: 10.1016/j.neures.2010.12.020 PMID: 21255620</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Singh, P.K.; Muqit, M.M.K. Parkinsons: A disease of aberrant vesicle trafficking. Annu. Rev. Cell Dev. Biol., 2020, 36(1), 237-264. doi: 10.1146/annurev-cellbio-100818-125512 PMID: 32749865</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Mao, Z.; Liu, C.; Ji, S.; Yang, Q.; Ye, H.; Han, H.; Xue, Z. The NLRP3 inflammasome is involved in the pathogenesis of Parkinsons disease in rats. Neurochem. Res., 2017, 42(4), 1104-1115. doi: 10.1007/s11064-017-2185-0 PMID: 28247334</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Hou, J.; Zhao, R.; Xia, W.; Chang, C.W.; You, Y.; Hsu, J.M.; Nie, L.; Chen, Y.; Wang, Y.C.; Liu, C.; Wang, W.J.; Wu, Y.; Ke, B.; Hsu, J.L.; Huang, K.; Ye, Z.; Yang, Y.; Xia, X.; Li, Y.; Li, C.W.; Shao, B.; Tainer, J.A.; Hung, M.C. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis. Nat. Cell Biol., 2020, 22(10), 1264-1275. doi: 10.1038/s41556-020-0575-z PMID: 32929201</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Wei, Q.; Mu, K.; Li, T.; Zhang, Y.; Yang, Z.; Jia, X.; Zhao, W.; Huai, W.; Guo, P.; Han, L. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Lab. Invest., 2014, 94(1), 52-62. doi: 10.1038/labinvest.2013.126 PMID: 24166187</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Yu, P; Zhang, X; Liu, N; Tang, L; Peng, C; Chen, X. Pyroptosis: Mechanisms and diseases. Signal Transduct Tar., 2021, 6(1) doi: 10.1038/s41392-021-00507-5</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Xu, Y.J.; Zheng, L.; Hu, Y.W.; Wang, Q. Pyroptosis and its relationship to atherosclerosis. Clin. Chim. Acta, 2018, 476, 28-37. doi: 10.1016/j.cca.2017.11.005 PMID: 29129476</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Yang, F.; Qin, Y.; Lv, J.; Wang, Y.; Che, H.; Chen, X.; Jiang, Y.; Li, A.; Sun, X.; Yue, E.; Ren, L.; Li, Y.; Bai, Y.; Wang, L. Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy. Cell Death Dis., 2018, 9(10), 1000. doi: 10.1038/s41419-018-1029-4 PMID: 30250027</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Hu, Y.F.; Chen, Y.J.; Lin, Y.J.; Chen, S.A. Inflammation and the pathogenesis of atrial fibrillation. Nat. Rev. Cardiol., 2015, 12(4), 230-243. doi: 10.1038/nrcardio.2015.2 PMID: 25622848</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Zhang, J.; Qiang, C.C.; Li, W.J.; Liu, L.J.; Lin, X.X.; Cheng, Y.J.; Tang, K.; Yao, F.J.; Wu, S.H. Effects of Nardostachys chinensis on spontaneous ventricular arrhythmias in rats with acute myocardial infarction. J. Cardiovasc. Pharmacol., 2014, 64(2), 127-133. doi: 10.1097/FJC.0000000000000096 PMID: 24662492</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Li, M; Xu, X; Yang, X; Kwong, JSW; Shang, H The cardioprotective and antiarrhythmic effects of Nardostachys chinensis in animal and cell experiments. BMC Complem Altern M., 2017, 17(1) doi: 10.1186/s12906-017-1910-1</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Abbasi, W.M.; Ahmad, S.; Perveen, S.; Rehman, T. Preliminary phytochemical analysis and in vivo evaluation of antipyretic effects of hydro-methanolic extract of Cleome scaposa leaves. J. Tradit. Complement. Med., 2018, 8(1), 147-149. doi: 10.1016/j.jtcme.2017.05.004 PMID: 29322003</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Hopkins, A.L. Network pharmacology. Nat. Biotechnol., 2007, 25(10), 1110-1111. doi: 10.1038/nbt1007-1110 PMID: 17921993</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Liu, H.; Wang, J.; Zhou, W.; Wang, Y.; Yang, L. Systems approaches and polypharmacology for drug discovery from herbal medicines: An example using licorice. J. Ethnopharmacol., 2013, 146(3), 773-793. doi: 10.1016/j.jep.2013.02.004 PMID: 23415946</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Karki, R.; Kanneganti, T.D. Diverging inflammasome signals in tumorigenesis and potential targeting. Nat. Rev. Cancer, 2019, 19(4), 197-214. doi: 10.1038/s41568-019-0123-y PMID: 30842595</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Man, S.M.; Kanneganti, T.D. Regulation of inflammasome activation. Immunol. Rev., 2015, 265(1), 6-21. doi: 10.1111/imr.12296 PMID: 25879280</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Xia, X.; Wang, X.; Cheng, Z.; Qin, W.; Lei, L.; Jiang, J.; Hu, J. The role of pyroptosis in cancer: Pro-cancer or pro-"host"? Cell Death Dis., 2019, 10(9), 650. doi: 10.1038/s41419-019-1883-8 PMID: 31501419</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Zhou, G.; Soufan, O.; Ewald, J.; Hancock, R.E.W.; Basu, N.; Xia, J. NetworkAnalyst 3.0: A visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res., 2019, 47(W1), W234-41.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Blaauw, Y.; Van Gelder, I.C.; Crijns, H.J. Treatment of atrial fibrillation. Br. Heart J., 2002, 88(4), 432-437. doi: 10.1136/heart.88.4.432 PMID: 12231613</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Jiang, X.; Luo, Y.; Wang, X.; Chen, Y.; Wang, T.; He, J.; Xia, Y.; Zhao, J.; Chai, X.; Yao, L.; Liu, C.; Chen, Y. Investigating the efficiency and tolerability of traditional Chinese formulas combined with antiarrhythmic agents for paroxysmal atrial fibrillation: A systematic review and Bayesian network meta-analysis. Phytomedicine, 2022, 94, 153832. doi: 10.1016/j.phymed.2021.153832 PMID: 34781230</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Kalifa, J.; Avula, U.M.R. The Chinese herb extract Wenxin Keli: Atrial selectivity from the Far East. Heart Rhythm, 2012, 9(1), 132-133. doi: 10.1016/j.hrthm.2011.11.030 PMID: 22116050</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Liu, Y.; Zhang, Z.; Yang, Y.; Zhang, N.; Li, G.; Liu, T. The Chinese herb extract Wenxin Keli: A promising agent for the management of atrial fibrillation. Int. J. Cardiol., 2016, 203, 614-615. doi: 10.1016/j.ijcard.2015.10.211 PMID: 26580340</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Ma, J.; Yin, C.; Ma, S.; Qiu, H.; Zheng, C. Chen, Q Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure. Drug Des. Devel. Ther., 2018, 12, 3407-3418. doi: 10.2147/DDDT.S182834</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Yang, H.J.; Kong, B.; Shuai, W.; Zhang, J.; Huang, H. Shensong Yangxin attenuates metabolic syndrome-induced atrial fibrillation via inhibition of ferroportin-mediated intracellular iron overload. Phytomedicine, 2022, 101, 154086. doi: 10.1016/j.phymed.2022.154086 PMID: 35421806</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Shalini, S.; Dorstyn, L.; Dawar, S.; Kumar, S. Old, new and emerging functions of caspases. Cell Death Differ., 2015, 22(4), 526-539. doi: 10.1038/cdd.2014.216 PMID: 25526085</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Simpson, C.D.; Anyiwe, K.; Schimmer, A.D. Anoikis resistance and tumor metastasis. Cancer Lett., 2008, 272(2), 177-185. doi: 10.1016/j.canlet.2008.05.029 PMID: 18579285</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Fritsch, M.; Günther, S.D.; Schwarzer, R.; Albert, M.C.; Schorn, F.; Werthenbach, J.P.; Schiffmann, L.M.; Stair, N.; Stocks, H.; Seeger, J.M.; Lamkanfi, M.; Krönke, M.; Pasparakis, M.; Kashkar, H. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature, 2019, 575(7784), 683-687. doi: 10.1038/s41586-019-1770-6 PMID: 31748744</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Mandal, R.; Barrón, J.C.; Kostova, I.; Becker, S.; Strebhardt, K. Caspase-8: The double-edged sword. Biochimica et Biophysica Acta (BBA) -. Rev. Can., 2020, 1873(2), 188357.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Newton, K.; Wickliffe, K.E.; Dugger, D.L.; Maltzman, A.; Roose-Girma, M.; Dohse, M.; Kőműves, L.; Webster, J.D.; Dixit, V.M. Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis. Nature, 2019, 574(7778), 428-431. doi: 10.1038/s41586-019-1548-x PMID: 31511692</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Orning, P.; Weng, D.; Starheim, K.; Ratner, D.; Best, Z.; Lee, B.; Brooks, A.; Xia, S.; Wu, H.; Kelliher, M.A.; Berger, S.B.; Gough, P.J.; Bertin, J.; Proulx, M.M.; Goguen, J.D.; Kayagaki, N.; Fitzgerald, K.A.; Lien, E. Pathogen blockade of TAK1 triggers caspase-8dependent cleavage of gasdermin D and cell death. Science, 2018, 362(6418), 1064-1069. doi: 10.1126/science.aau2818 PMID: 30361383</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Charitakis, E.; Karlsson, L.O.; Papageorgiou, J.M.; Walfridsson, U.; Carlhäll, C.J. Echocardiographic and biochemical factors predicting arrhythmia recurrence after catheter ablation of atrial fibrillation-an observational study. Front. Physiol., 2019, 10, 1215. doi: 10.3389/fphys.2019.01215 PMID: 31632285</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Hiram, R.; Xiong, F.; Naud, P.; Xiao, J.; Sirois, M.; Tanguay, J.F.; Tardif, J.C.; Nattel, S. The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease. Cardiovasc. Res., 2021, 117(7), 1776-1789. doi: 10.1093/cvr/cvaa186 PMID: 32866246</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Kalliolias, G.D.; Ivashkiv, L.B. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat. Rev. Rheumatol., 2016, 12(1), 49-62. doi: 10.1038/nrrheum.2015.169 PMID: 26656660</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Micheau, O.; Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell, 2003, 114(2), 181-190. doi: 10.1016/S0092-8674(03)00521-X PMID: 12887920</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Liew, R.; Khairunnisa, K.; Gu, Y.; Tee, N.; Yin, N.O.; Naylynn, T.M.; Moe, K.T. Role of tumor necrosis factor-α in the pathogenesis of atrial fibrosis and development of an arrhythmogenic substrate. Circ. J., 2013, 77(5), 1171-1179. doi: 10.1253/circj.CJ-12-1155 PMID: 23370453</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Ren, M.; Li, X.; Hao, L.; Zhong, J. Role of tumor necrosis factor alpha in the pathogenesis of atrial fibrillation: A novel potential therapeutic target? Ann. Med., 2015, 47(4), 316-324. doi: 10.3109/07853890.2015.1042030 PMID: 25982799</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Ye, T.; Zhang, C.; Wu, G.; Wan, W.; Liang, J.; Liu, X.; Liu, D.; Yang, B. Pinocembrin attenuates autonomic dysfunction and atrial fibrillation susceptibility via inhibition of the NF-κB/TNF-α pathway in a rat model of myocardial infarction. Int. Immunopharmacol., 2019, 77, 105926. doi: 10.1016/j.intimp.2019.105926 PMID: 31704291</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Ding, S.; Liu, D.; Wang, L.; Wang, G.; Zhu, Y. Inhibiting MicroRNA-29a protects myocardial ischemia-reperfusion injury by targeting SIRT1 and suppressing oxidative stress and NLRP3-mediated pyroptosis pathway. J. Pharmacol. Exp. Ther., 2020, 372(1), 128-135. doi: 10.1124/jpet.119.256982 PMID: 31481517</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Li, Z.; Liu, T.; Feng, Y.; Tong, Y.; Jia, Y.; Wang, C. PPARγ alleviates sepsis-induced liver injury by inhibiting hepatocyte pyroptosis via inhibition of the ROS/TXNIP/NLRP3 signaling pathway. Oxid. Med. Cell. Longev., 2022, 2022, 1-15. doi: 10.1155/2022/8999899</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Wang, N.; Kong, R.; Han, W.; Bao, W.; Shi, Y.; Ye, L.; Lu, J. Honokiol alleviates ulcerative colitis by targeting PPAR-γTLR4NF-κB signaling and suppressing gasdermin-D-mediated pyroptosis in vivo and in vitro. Int. Immunopharmacol., 2022, 111, 109058. doi: 10.1016/j.intimp.2022.109058 PMID: 35901530</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Pinzi, L.; Rastelli, G. Molecular docking: Shifting paradigms in drug discovery. Int. J. Mol. Sci., 2019, 20(18), 4331. doi: 10.3390/ijms20184331 PMID: 31487867</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Rehman, T.; Ahmad, S. Nardostachys chinensis Batalin: A review of traditional uses, phytochemistry, and pharmacology. Phytother. Res., 2019, 33(10), 2622-2648. doi: 10.1002/ptr.6447 PMID: 31359527</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Li, G.R.; Wang, H.B.; Qin, G.W.; Jin, M.W.; Tang, Q.; Sun, H.Y.; Du, X.L.; Deng, X.L.; Zhang, X.H.; Chen, J.B.; Chen, L.; Xu, X.H.; Cheng, L.C.; Chiu, S.W.; Tse, H.F.; Vanhoutte, P.M.; Lau, C.P. Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs. Circulation, 2008, 117(19), 2449-2457. doi: 10.1161/CIRCULATIONAHA.108.769554 PMID: 18458165</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Zhu, Y.; Bu, J.; Shi, S.; Wang, H-Q.; Niu, X-S.; Zhao, Z-F.; Wu, W-D.; Zhang, X-L.; Ma, Z.; Zhang, Y.J.; Zhang, H. Acacetin protects against cerebral ischemia-reperfusion injury via the NLRP3 signaling pathway. Neural Regen. Res., 2019, 14(4), 605-612. doi: 10.4103/1673-5374.247465 PMID: 30632500</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Bak, M.J.; Hong, S.G.; Lee, J.W.; Jeong, W.S. Red ginseng marc oil inhibits iNOS and COX-2 via NFκB and p38 pathways in LPS-stimulated RAW 264.7 macrophages. Molecules, 2012, 17(12), 13769-13786. doi: 10.3390/molecules171213769 PMID: 23174895</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Li, W.; Cao, T.; Luo, C.; Cai, J.; Zhou, X.; Xiao, X.; Liu, S. Crosstalk between ER stress, NLRP3 inflammasome, and inflammation. Appl. Microbiol. Biotechnol., 2020, 104(14), 6129-6140. doi: 10.1007/s00253-020-10614-y PMID: 32447438</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Liu, H.; Zhan, X.; Xu, G.; Wang, Z.; Li, R.; Wang, Y.; Qin, Q.; Shi, W.; Hou, X.; Yang, R.; Wang, J.; Xiao, X.; Bai, Z. Cryptotanshinone specifically suppresses NLRP3 inflammasome activation and protects against inflammasome-mediated diseases. Pharmacol. Res., 2021, 164, 105384. doi: 10.1016/j.phrs.2020.105384 PMID: 33352229</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Han, X.; Wu, Y.C.; Meng, M.; Sun, Q.S.; Gao, S.M.; Sun, H. Linarin prevents LPS induced acute lung injury by suppressing oxidative stress and inflammation via inhibition of TXNIP/NLRP3 and NF κB pathways. Int. J. Mol. Med., 2018, 42(3), 1460-1472. doi: 10.3892/ijmm.2018.3710 PMID: 29845284</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Coll, R.C.; Schroder, K.; Pelegrín, P. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharmacol. Sci., 2022, 43(8), 653-668. doi: 10.1016/j.tips.2022.04.003 PMID: 35513901</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Ajoolabady, A.; Nattel, S.; Lip, G.Y.H.; Ren, J. Inflammasome signaling in atrial fibrillation. J. Am. Coll. Cardiol., 2022, 79(23), 2349-2366. doi: 10.1016/j.jacc.2022.03.379 PMID: 35680186</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>Yao, C.; Veleva, T.; Scott, L., Jr; Cao, S.; Li, L.; Chen, G.; Jeyabal, P.; Pan, X.; Alsina, K.M.; Abu-Taha, I.; Ghezelbash, S.; Reynolds, C.L.; Shen, Y.H.; LeMaire, S.A.; Schmitz, W.; Müller, F.U.; El-Armouche, A.; Tony Eissa, N.; Beeton, C.; Nattel, S.; Wehrens, X.H.T.; Dobrev, D.; Li, N. Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation. Circulation, 2018, 138(20), 2227-2242. doi: 10.1161/CIRCULATIONAHA.118.035202 PMID: 29802206</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Zhang, Y.; Zhang, S.; Li, B.; Luo, Y.; Gong, Y.; Jin, X.; Zhang, J.; Zhou, Y.; Zhuo, X.; Wang, Z.; Zhao, X.; Han, X.; Gao, Y.; Yu, H.; Liang, D.; Zhao, S.; Sun, D.; Wang, D.; Xu, W.; Qu, G.; Bo, W.; Li, D.; Wu, Y.; Li, Y. Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome. Cardiovasc. Res., 2022, 118(3), 785-797. doi: 10.1093/cvr/cvab114 PMID: 33757127</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>Lawlor, K.E.; Khan, N.; Mildenhall, A.; Gerlic, M.; Croker, B.A.; DCruz, A.A.; Hall, C.; Kaur Spall, S.; Anderton, H.; Masters, S.L.; Rashidi, M.; Wicks, I.P.; Alexander, W.S.; Mitsuuchi, Y.; Benetatos, C.A.; Condon, S.M.; Wong, W.W.L.; Silke, J.; Vaux, D.L.; Vince, J.E. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nat. Commun., 2015, 6(1), 6282. doi: 10.1038/ncomms7282 PMID: 25693118</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>Zhou, R.; Jin, D.; Zhang, Y.; Duan, L.; Zhang, Y.; Duan, Y.; Kang, X.; Lian, F. Investigating the mechanisms of pollen typhae in the treatment of diabetic retinopathy based on network pharmacology and molecular docking. Evid. Based Complement. Alternat. Med., 2022, 2022, 1-14. doi: 10.1155/2022/5728408 PMID: 35024051</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>Chen, H.; Deng, Y.; Gan, X.; Li, Y.; Huang, W.; Lu, L.; Wei, L.; Su, L.; Luo, J.; Zou, B.; Hong, Y.; Cao, Y.; Liu, Y.; Chi, W. NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma. Mol. Neurodegener., 2020, 15(1), 26. doi: 10.1186/s13024-020-00372-w PMID: 32295623</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation>Messaoud-Nacer, Y.; Culerier, E.; Rose, S.; Maillet, I.; Rouxel, N.; Briault, S.; Ryffel, B.; Quesniaux, V.F.J.; Togbe, D. STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS). Cell Death Dis., 2022, 13(3), 269. doi: 10.1038/s41419-022-04664-5 PMID: 35338116</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation>Roy, P.; Orecchioni, M.; Ley, K. How the immune system shapes atherosclerosis: Roles of innate and adaptive immunity. Nat. Rev. Immunol., 2022, 22(4), 251-265. doi: 10.1038/s41577-021-00584-1</mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation>Poli, A.; Michel, T.; Thérésine, M.; Andrès, E.; Hentges, F.; Zimmer, J. CD56 bright natural killer (NK) cells: An important NK cell subset. Immunology, 2009, 126(4), 458-465. doi: 10.1111/j.1365-2567.2008.03027.x PMID: 19278419</mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation>Zhang, Z.; Zhang, Y.; Xia, S.; Kong, Q.; Li, S.; Liu, X. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature, 2020, 579(7799), 415-420.</mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation>Kazem, N.; Sulzgruber, P.; Thaler, B.; Baumgartner, J.; Koller, L.; Laufer, G.; Steinlechner, B.; Hohensinner, P.; Wojta, J.; Niessner, A. CD8+CD28null T lymphocytes are associated with the development of atrial fibrillation after elective cardiac surgery. Thromb. Haemost., 2020, 120(8), 1182-1187. doi: 10.1055/s-0040-1713096 PMID: 32594507</mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation>Hammer, A.; Niessner, A.; Sulzgruber, P. The impact of CD4+CD28null T lymphocytes on atrial fibrillation: a potential pathophysiological pathway. Inflamm. Res., 2021, 70(10-12), 1011-1014. doi: 10.1007/s00011-021-01502-w PMID: 34536081</mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation>Jiao, Y.; Zhang, T.; Zhang, C.; Ji, H.; Tong, X.; Xia, R.; Wang, W.; Ma, Z.; Shi, X. Exosomal miR-30d-5p of neutrophils induces M1 macrophage polarization and primes macrophage pyroptosis in sepsis-related acute lung injury. Crit. Care, 2021, 25(1), 356. doi: 10.1186/s13054-021-03775-3 PMID: 34641966</mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation>Sun, Z.; Zhou, D.; Xie, X.; Wang, S.; Wang, Z.; Zhao, W.; Xu, H.; Zheng, L. Cross-talk between macrophages and atrial myocytes in atrial fibrillation. Basic Res. Cardiol., 2016, 111(6), 63. doi: 10.1007/s00395-016-0584-z PMID: 27660282</mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation>Zhang, Z.; Zhang, D.; Xie, K.; Wang, C.; Xu, F. Luteolin activates Tregs to promote IL-10 expression and alleviating caspase-11-dependent pyroptosis in sepsis-induced lung injury. Int. Immunopharmacol., 2021, 99, 107914. doi: 10.1016/j.intimp.2021.107914 PMID: 34246059</mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation>Yan, W.; Zhao, Y.; Xie, K.; Xing, Y.; Xu, F. Aspergillus fumigatus influences gasdermin-d-dependent pyroptosis of the lung via regulating toll-like receptor 2-mediated regulatory T cell differentiation. J. Immunol. Res., 2021, 2021, 1-14. doi: 10.1155/2021/5538612 PMID: 34222495</mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation>Chen, Y.; Chang, G.; Chen, X.; Li, Y.; Li, H.; Cheng, D.; Tang, Y.; Sang, H. IL-6-miR-210 suppresses regulatory T cell function and promotes atrial fibrosis by targeting foxp3. Mol. Cells, 2020, 43(5), 438-447. PMID: 32345003</mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation>Zhang, Y.; Sun, D.; Zhao, X.; Luo, Y.; Yu, H.; Zhou, Y.; Gao, Y.; Han, X.; Duan, Y.; Fang, N.; Duan, X.; Li, T.; Zhang, S.; Gong, Y.; Li, Y. Bacteroides fragilis prevents aging-related atrial fibrillation in rats via regulatory T cells-mediated regulation of inflammation. Pharmacol. Res., 2022, 177, 106141. doi: 10.1016/j.phrs.2022.106141 PMID: 35202820</mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation>Du, Y.; Du, L.; He, Z.; Zhou, J.; Wen, C.; Zhang, Y. Cryptotanshinone ameliorates the pathogenesis of systemic lupus erythematosus by blocking T cell proliferation. Int. Immunopharmacol., 2019, 74, 105677. doi: 10.1016/j.intimp.2019.105677 PMID: 31177018</mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation>Zhao, N.; Dong, Q.; Fu, X.X.; Du, L.L.; Cheng, X.; Du, Y.M.; Liao, Y.H. Acacetin blocks kv1.3 channels and inhibits human T cell activation. Cell. Physiol. Biochem., 2014, 34(4), 1359-1372. doi: 10.1159/000366343 PMID: 25301362</mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation>Liu, L.; Yang, J.; Zu, B.; Wang, J.; Sheng, K.; Zhao, L.; Xu, W. Acacetin regulated the reciprocal differentiation of Th17 cells and Treg cells and mitigated the symptoms of collagen‐induced arthritis in mice. Scand. J. Immunol., 2018, 88(4), e12712. doi: 10.1111/sji.12712 PMID: 30176062</mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation>Chen, X.; Zhang, S.; Xuan, Z.; Ge, D.; Chen, X.; Zhang, J.; Wang, Q.; Wu, Y.; Liu, B. The phenolic fraction of mentha haplocalyx and its constituent linarin ameliorate inflammatory response through inactivation of NF-κB and MAPKs in lipopolysaccharide-induced RAW264.7 cells. Molecules, 2017, 22(5), 811. doi: 10.3390/molecules22050811 PMID: 28509854</mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation>Ren, J.; Yue, B.; Wang, H.; Zhang, B.; Luo, X.; Yu, Z.; Zhang, J.; Ren, Y.; Mani, S.; Wang, Z.; Dou, W. Acacetin ameliorates experimental colitis in mice via inhibiting macrophage inflammatory response and regulating the composition of gut microbiota. Front. Physiol., 2021, 11, 577237. doi: 10.3389/fphys.2020.577237 PMID: 33536931</mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation>Chiou, W.F.; Don, M.J. Cryptotanshinone inhibits macrophage migration by impeding F-actin polymerization and filopodia extension. Life Sci., 2007, 81(2), 109-114. doi: 10.1016/j.lfs.2007.04.028 PMID: 17568618</mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation>Wang, H.; Chen, Y.; Tao, T.; Zhao, X.; Wang, Y.; Luo, J.; Guo, Y. Identification of microRNA biomarkers in serum of patients at different stages of atrial fibrillation. Heart Lung, 2020, 49(6), 902-908. doi: 10.1016/j.hrtlng.2020.03.021 PMID: 32482362</mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation>Zhu, Y.; Feng, Z.; Cheng, W.; Xiao, Y. MicroRNA 34a mediates atrial fibrillation through regulation of Ankyrin B expression. Mol. Med. Rep., 2018, 17(6), 8457-8465. doi: 10.3892/mmr.2018.8873 PMID: 29658562</mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation>Zheng, Q.; Lin, R.; Chen, Y.; Lv, Q.; Zhang, J.; Zhai, J.; Xu, W.; Wang, W. SARS-CoV-2 induces "cytokine storm" hyperinflammatory responses in RA patients through pyroptosis. Front. Immunol., 2022, 13, 1058884. doi: 10.3389/fimmu.2022.1058884 PMID: 36532040</mixed-citation></ref></ref-list></back></article>
